Witherspoon Charles's Form 4 filing
West Pharmaceutical Services Inc (WST) · filed Nov 2, 2023
- Accession no.
- 0001127602-23-026551
- Filed
- Nov 2, 2023
- Trade date
- Oct 31, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $383.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Witherspoon CharlesCIK 0001731739 | Officer (VP & Treasurer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 31, 2023 | Common Stock | MOption exerciseAcquired | +594 | $173.22 | +$102,892.68 | 2,429.09 | Direct | |
| Oct 31, 2023 | Common Stock | MOption exerciseAcquired | +596 | $274.29 | +$163,476.84 | 3,025.09 | Direct | |
| Oct 31, 2023 | Common Stock | SSaleDisposed | −594 | $322.48 | −$191,553.12 | 2,431.09 | Direct | |
| Oct 31, 2023 | Common Stock | SSaleDisposed | −596 | $322.27 | −$192,072.92 | 1,835.09 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 31, 2023 | Stock Options (Right to Buy) | MOption exerciseDisposed | −594 | $0.00 | $0 | 478 | Direct | |
| Oct 31, 2023 | Stock Options (Right to Buy) | MOption exerciseDisposed | −596 | $0.00 | $0 | 596 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.